Genetic determinants of hepatitis B vaccine response
2011
Genetic Factors Affecting Hepatitis B Vaccine Response
Sample size: 4300
publication
Evidence: moderate
Author Information
Author(s): Png Eileen, Thalamuthu Anbupalam, Ong Rick TH, Snippe Harm, Sudoyo Herawati, Muljono David H, Marzuki Sangkot, Boland Greet J, Seielstad Mark
Primary Institution: Genome Institute of Singapore
Hypothesis
There is genetic variation influencing the immune response to the hepatitis B vaccine.
Conclusion
The study identified several genetic regions associated with vaccine response in hepatitis B.
Supporting Evidence
- Approximately one-third of the world’s population has serological evidence of hepatitis B virus infection.
- 350 million people are carriers of chronic HBV infection.
- About a million carriers die each year from chronic liver disease.
- HBV is a vaccine preventable disease.
- 10% of the population fails to mount a protective immune response after vaccination.
- Twin studies suggest a high heritability of the vaccine response trait.
- The study genotyped 2000 vaccinees in the first stage and 2300 in the second stage.
Takeaway
Some people don't respond well to the hepatitis B vaccine, and scientists are looking for genes that might explain why.
Methodology
A two-stage Genome Wide Association Scan (GWAS) was performed on participants from a vaccine efficacy trial.
Participant Demographics
Participants were vaccinees from Batam, Indonesia.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website